References
- Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64:12–17.
- WorldWide Antimalarial Resistance Network. K13 molecular surveyor - Southeast Asia. [cited 2016 Mar 7]. Available from: http://www.wwarn.org/molecular/surveyor/k13/index.html?t=201505211240#0
- Tun KM, Imwong M, Lwin KM, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415–421.
- Amaratunga C, Lim P, Suon S, et al. Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016. doi:10.1016/S1473-3099(15)00487-9.
- Noranate N, Durand R, Tall A, et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One. 2007;2:e139.
- Newton PN, Green MD, Fernández FM, et al. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006;6:602–613.
- Tabernero P, Fernández FM, Green M, et al. Mind the gaps–the epidemiology of poor-quality anti-malarials in the malarious world–analysis of the worldwide antimalarial resistance network database. Malar J. 2014;13:139.
- Newton PN, Amin AA, Bird C, et al. The primacy of public health considerations in defining poor quality medicines. PLoS Med. 2011;8:e1001139.
- WWARN - Antimalarial Quality Literature Surveyor. [cited 2016 Mar 7]. Available from: http://www.wwarn.org/aqsurveyor/#0
- Newton PN, Lee SJ, Goodman C, et al. Guidelines for field surveys of the quality of medicines: a proposal. PLoS Med. 2009;6:e52.
- Newton PN, Tabernero P, Dwivedi P, et al. Falsified medicines in Africa: all talk, no action. Lancet Glob Heal. 2014;2:e509–10.
- Sengaloundeth S, Green MD, Fernández FM, et al. A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance. Malar J. 2009;8:172.
- Tabernero P, Mayxay M, Culzoni MJ, et al. A repeat random survey of the prevalence of falsified and substandard antimalarials in the Lao PDR: a change for the better. Am J Trop Med Hyg. 2015;92:95–104.
- ACT Consortium Drug Quality Project and IMPACT Study Team. Quality of artemisinin-containing antimalarials in Tanzania’s private sector–Results from a nationally representative outlet survey. Am J Trop Med Hyg. 2015;92:75–86.
- Renschler JP, Walters KM, Newton PN, et al. Estimated under-five deaths associated with poor-quality antimalarials in sub-saharan Africa. Am J Trop Med Hyg. 2015;92:119–126.
- Payne D. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol Today. 1988;4:112–115.
- Petralanda I. Quality of antimalarial drugs and resistance to Plasmodium vivax in Amazonian region. Lancet. 1995;345:1433.
- Leslie T, Kaur H, Mohammed N, et al. Epidemic of Plasmodium falciparum malaria involving substandard antimalarial drugs, Pakistan, 2003. Emerg Infect Dis. 2009;15:1753–1759.
- White NJ, Pongtavornpinyo W, Maude RJ, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009;8:253.
- Newton PN, Fernández FM, Green MD, et al. Counterfeit and substandard anti-infectives in developing countries. In: Sosa AJ, Byarugaba DK, Amábile-Cuevas CF, Hsueh P-R, Kariuki S, Okeke IN, editor. Antimicrobial resistance in developing countries. New York: Springer; 2009. p. 413–443.
- Dondorp AM, Fanello CI, Hendriksen ICE, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376:1647–1657.
- Newton PN, Green MD, Mildenhall DC, et al. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J. 2011;10:352.
- Hall KA, Newton PN, Green MD, et al. Characterization of counterfeit artesunate antimalarial tablets from southeast Asia. Am J Trop Med Hyg. 2006;75:804–811.
- Frosch AEP, Laufer MK, Mathanga DP, et al. Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi. J Infect Dis. 2014;210:1110–1114.